Press releases - Aenitis

Press releases

Bracco and Aenitis Join Forces to Develop “Acoustic Beads” for Advanced Rare and Complex Cell Sorting in Flow Processes

Access the full Press Release: English Version / French Version ● Pioneering industry collaboration: Bracco and Aenitis join forces to combine expertise in acoustophoresis and functionalised microsystems to revolutionise the sorting of rare and complex cells, driving innovation in biomanufacturing and advanced therapies● Transformative alternative for sorting rare and complex cells: Acoustic microspheres offer a new alternative to magnetic beads, enabling safer, more efficient and scalable solutions● This pioneering technology ensures biocompatibility, improved cell viability and cost-effective processing, making large-scale sorting of rare and complex cells faster and more accessible Paris, France, January 8, 2025 – Aenitis Technologies,

Press releases

Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology (2024)

Access the full Press Release: English Version / French Version ● Aenitis is set to transform the bioproduction industry by addressing theincreasing need for scalable, cost-effective, and highly precise cell processingtechnologies.● Mitis™, the flagship product of its unique Acoustofluidic Technology, is alreadyused across various applications, from research to clinical and industrial scales,including cell sorting, isolation, concentration, and washing.● Funding round led by the European Innovation Council Fund, Quadrivium I fund(Seventure Partners) and Mifani Invest to support commercial launch and globalexpansion. Paris, France, October 10, 2024-– Aenitis Technologies, a pioneer in acoustic-based cellmanipulation, has successfully closed

Press releases

Aenitis h2020 (2017)

Read the entire press release This funding will help to accelerate the roll-out of acoustic blood cell sorting technology to industrial scale Aenitis Technologies, which develops new medical equipment based on acoustic manipulation of biological particles, today announced that it has received €4 million in funding, following its application to the highly-selective SME Instrument Phase 2 European programme, in the “Healthcare Biotechnology” category. SME Instrument Phase 2 is part of Horizon 2020, a programme managed by the European Commission and dedicated to innovation and research. It is part of the Industrial Leadership pillar of H2020

Press releases

Aenitis CNRS (2016)

Paris, October 19, 2016 – Aenitis Technologies, a company that develops new medical devices based on acoustic manipulation mechanisms for biological particles, is announcing that FIST SA, the CNRS’ technology exploitation subsidiary, has acquired an interest in its capital ‍ France Innovation Scientifique et Transfert SA (FIST SA) has established a stake in the capital of the company founded in July 2014 by Mauricio Hoyos and Jean-Luc Aider, two CNRS research scientists working in the Laboratory of Physics and Mechanics of Heterogeneous Environments (CNRS, ESPCI, UPMC, Université Paris Diderot), and Emmanuel Vincent. Aenitis Technologies is

Press releases

Aenitis i-lab (2015)

Paris, July 2, 2015 – Aenitis Technologies : Winner of 17th Contest in Category I-lab Creation Development of the Ministry of Research and Higher Education. Created in July 2014, Aenitis Technologies is a young French start-up from born from the work of Mauricio Hoyos and Jean-Luc AIDER, researchers at the CNRS Laboratory of Physics and Mechanics of Heterogeneous Media (PMMH) at ESPCI. The company focuses its activities in the medical devices sector where the impact of technology breaks it develops strongly wearer.. This significant support from the Ministry of Research and Higher Education will contribute